Astro-Med, Inc. 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Astro-Med, Inc., covering the period ended August 3, 1996. The company manufactures recorder and data acquisition products, media products, and operates the Grass Instruments Division. International markets accounted for 28% of net sales during the quarter.
Key Financial Metrics
| Metric | Three Months Ended Aug 3, 1996 | Six Months Ended Aug 3, 1996 |
|---|---|---|
| Net Sales | $11,178,773 | $21,668,594 |
| Gross Profit | $4,402,945 (39% margin) | $8,361,240 (39% margin) |
| Operating Income | $674,242 | $675,356 |
| Net Income | $586,468 | $1,029,584 |
| Earnings Per Share | $0.12 | $0.20 |
| Cash and Equivalents (End of Period) | $5,202,209 | $5,202,209 |
| Working Capital | $28,200,000 | N/A |
| Current Ratio | 7:1 | N/A |
| Long-Term Debt | $125,000 | $125,000 |
Material Changes vs. Prior Period
- Revenue: Second-quarter net sales increased 4% year-over-year. Six-month sales were virtually flat compared to the prior year.
- Margins: Gross profit margin declined to 39% in the second quarter from 43% a year ago, attributed to product mix. Six-month margins were 39% versus 41% previously.
- Expenses: Operating expenses decreased 8% in the quarter and 5% for the six-month period due to controlled selling and administrative costs.
- Other Income: Other income increased significantly to $165,226 for the quarter (from $120,278) and $698,228 for six months (from $395,002), driven by gains on the sale of investment securities and higher interest income.
- Cash Flow: Net cash provided by operating activities improved to $2,473,026 for the six months, compared to a net use of $68,408 in the prior year period. Total cash increased by $3,168,496.
Outlook, Risks, and Management Commentary
Management expects increased demand for core products and new offerings (Sundance printer line, Astro-DAQ) to drive higher gross profit margins. The company continues to expand internationally. No additional long-term financing is currently planned.
Risks and Contingencies: Forward-looking statements are subject to risks including product demand, market acceptance, competitive pricing, development delays, supply constraints, and international trade restrictions.
Investor Verification Checklist
- Verify the sustainability of the 4% sales growth given the flat six-month trend.
- Confirm the impact of product mix on the declining gross margin (39% vs 43% prior year).
- Assess the one-time nature of the $416,090 gain on sale of investments included in other income.
- Review the 28% exposure to international markets and associated trade risks.
- Monitor inventory levels, which decreased by $859,510 in the six-month period, contributing to cash flow.